Published in Dis Colon Rectum on April 01, 1995
Clostridium difficile-associated diarrhea in adults. CMAJ (2004) 4.27
ICD-9 codes and surveillance for Clostridium difficile-associated disease. Emerg Infect Dis (2006) 2.27
Hospitalized Patients with Cirrhosis Should Be Screened for Clostridium difficile Colitis. Dig Dis Sci (2015) 2.03
Clostridium difficile associated infection, diarrhea and colitis. World J Gastroenterol (2009) 1.97
Intravenous immunoglobulin therapy for severe Clostridium difficile colitis. Gut (1997) 1.96
Clinical risk factors for severe Clostridium difficile-associated disease. Emerg Infect Dis (2009) 1.95
Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection. Clin Infect Dis (2013) 1.95
Binary toxin and death after Clostridium difficile infection. Emerg Infect Dis (2011) 1.79
Prediction tools for unfavourable outcomes in Clostridium difficile infection: a systematic review. PLoS One (2012) 1.19
Intravenous immunoglobulin for the treatment of Clostridium difficile infection: a review. Dig Dis Sci (2010) 1.13
Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment. World J Gastroenterol (2013) 1.03
Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy. BMC Infect Dis (2013) 1.02
Variations in virulence and molecular biology among emerging strains of Clostridium difficile. Microbiol Mol Biol Rev (2013) 0.99
Clostridium difficile infection in the intensive care unit. Infect Dis Clin North Am (2009) 0.93
The impact of Clostridium difficile on a surgical service: a prospective study of 374 patients. Ann Surg (1998) 0.91
Univariate and multivariate analysis of risk factors for severe Clostridium difficile-associated diarrhoea: importance of co-morbidity and serum C-reactive protein. World J Gastroenterol (2008) 0.90
Clinical factors associated with development of severe-complicated Clostridium difficile infection. Clin Gastroenterol Hepatol (2013) 0.89
The potential value of Clostridium difficile vaccine: an economic computer simulation model. Vaccine (2010) 0.87
Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections. World J Gastroenterol (2016) 0.86
Recombinant single-chain variable fragment antibodies directed against Clostridium difficile toxin B produced by use of an optimized phage display system. Clin Diagn Lab Immunol (2003) 0.86
Derivation and validation of a simple, accurate and robust prediction rule for risk of mortality in patients with Clostridium difficile infection. BMC Infect Dis (2013) 0.85
Prolonged ileus as a sole manifestation of pseudomembranous enterocolitis. Int J Colorectal Dis (2003) 0.84
Avoiding pitfalls: what an endoscopist should know in liver transplantation--part II. Dig Dis Sci (2008) 0.84
Clinical predictors of fulminant colitis in patients with Clostridium difficile infection. Saudi J Gastroenterol (2012) 0.80
Risk Factors for the Development of Clostridium difficile-associated Colitis after Colorectal Cancer Surgery. J Korean Soc Coloproctol (2010) 0.79
Fucoidin prevents Clostridium difficile toxin-A-induced ileal enteritis in mice. Dig Dis Sci (2007) 0.79
Clinical and Microbiologic Characteristics of Clostridium difficile Infection Caused by Binary Toxin Producing Strain in Korea. Infect Chemother (2013) 0.78
Cost of hospital management of Clostridium difficile infection in United States-a meta-analysis and modelling study. BMC Infect Dis (2016) 0.75
Clostridium difficile-associated diarrhea in dialysis patients. Kidney Res Clin Pract (2012) 0.75
Fulminant, non-antibiotic associated Clostridium difficile colitis following Salmonella gastroenteritis. J Gen Intern Med (2010) 0.75
Management of severe Clostridium difficile-associated diarrhea. Dig Dis Sci (2009) 0.75
Role of superficial femoral artery puncture in the development of pseudoaneurysm and arteriovenous fistula complicating percutaneous transfemoral cardiac catheterization. Cathet Cardiovasc Diagn (1992) 1.82
High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis. J Clin Invest (2000) 1.67
Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor. J Biol Chem (1994) 1.46
Sequential helical CT angiography of aortoiliac disease. AJR Am J Roentgenol (1996) 1.44
Two decades of abdominal aortic aneurysm repair: have we made any progress? J Vasc Surg (2000) 1.42
The cost-effectiveness of endovascular repair versus open surgical repair of abdominal aortic aneurysms: A decision analysis model. J Vasc Surg (1999) 1.22
Mechanisms of post-intervention arterial remodelling. Cardiovasc Res (2012) 1.13
Elevated Egr-1 in human atherosclerotic cells transcriptionally represses the transforming growth factor-beta type II receptor. J Biol Chem (2000) 1.08
Enhancement of migration by protein kinase Calpha and inhibition of proliferation and cell cycle progression by protein kinase Cdelta in capillary endothelial cells. J Biol Chem (1997) 1.08
Identification and functional characterization of protein kinase C isozymes in platelets and HEL cells. J Biol Chem (1992) 1.03
Smooth muscle cell migration and proliferation are mediated by distinct phases of activation of the intracellular messenger mitogen-activated protein kinase. J Vasc Surg (1998) 1.00
Differential effects of platelet-derived growth factor isotypes on human smooth muscle cell proliferation and migration are mediated by distinct signaling pathways. Surgery (1996) 0.99
Mitogen-activated protein kinase and proliferation of human vascular smooth muscle cells. Am J Physiol (1996) 0.98
The role of integrins in saphenous vein vascular smooth muscle cell migration. J Vasc Surg (1997) 0.98
Lower extremity spiral CT angiography versus catheter angiography. Radiology (1995) 0.96
What is the proper role of polytetrafluoroethylene grafts in infrainguinal reconstruction? J Vasc Surg (1989) 0.94
Balloon catheterization induced arterial expression of embryonic fibronectins. Arterioscler Thromb Vasc Biol (1995) 0.92
Preoperative assessment of the carotid bifurcation. Can magnetic resonance angiography and duplex ultrasonography replace contrast arteriography? Stroke (1995) 0.91
Contrast-enhanced peripheral MR angiography from the abdominal aorta to the pedal arteries: combined dynamic two-dimensional and bolus-chase three-dimensional acquisitions. Invest Radiol (2001) 0.91
Differential effects of protein kinase C on human vascular smooth muscle cell proliferation and migration. Am J Physiol Heart Circ Physiol (2001) 0.90
Alternative splicing produces a divergent cytoplasmic tail in the human endothelial thromboxane A2 receptor. J Biol Chem (1995) 0.89
Simultaneous occurrence of superficial and deep thrombophlebitis in the lower extremity. J Vasc Surg (1990) 0.89
Dynamic contrast-enhanced subtraction MR angiography of the lower extremities: initial evaluation with a multisection two-dimensional time-of-flight sequence. Radiology (1995) 0.89
Is carotid endarterectomy cost-effective? An analysis of symptomatic and asymptomatic patients. Circulation (1996) 0.88
Percutaneous catheter drainage of infected intra-abdominal fluid collections. American College of Radiology. ACR Appropriateness Criteria. Radiology (2000) 0.88
Transforming growth factor-beta inhibits human vascular smooth muscle cell growth and migration. Surgery (1993) 0.87
Is lower extremity revascularization worthwhile in patients with end-stage renal disease? Surgery (2000) 0.86
Activation of integrin receptors is required for growth factor-induced smooth muscle cell dysfunction. J Vasc Surg (2000) 0.86
Activation of pp60c-src is necessary for human vascular smooth muscle cell migration. Surgery (1997) 0.85
Use of heat shock for culturing Clostridium difficile from rectal swabs. Clin Infect Dis (1993) 0.83
MR angiography of the carotid bifurcation: artifacts and limitations. AJR Am J Roentgenol (1994) 0.83
The effect of protein kinase C and its alpha subtype on human vascular smooth muscle cell proliferation, migration and fibronectin production. Surgery (2000) 0.82
Extracellular matrix proteins are potent agonists of human smooth muscle cell migration. J Vasc Surg (1996) 0.82
Role of protein kinase C in attachment, spreading, and migration of human endothelial cells. J Surg Res (1996) 0.82
Evaluation of the extracranial carotid arteries: correlation of magnetic resonance angiography, duplex ultrasonography, and conventional angiography. J Vasc Surg (1991) 0.81
The effect of growth factors, cytokines, and extracellular matrix proteins on fibronectin production in human vascular smooth muscle cells. J Vasc Surg (2000) 0.80
Abdominal aorta and renal artery stenosis: evaluation with MR angiography. Radiology (1990) 0.79
Improving cost efficiency on a vascular surgery service. Am J Surg (2000) 0.79
Duplex ultrasound criteria for the identification of carotid stenosis should be laboratory specific. Stroke (1997) 0.79
Do neck incisions influence nerve deficits after carotid endarterectomy? Arch Surg (1994) 0.78
Peripheral directional atherectomy: 4-year experience. Radiology (1992) 0.78
Effect of angiotensin II on human vascular smooth muscle cell growth. J Surg Res (1994) 0.78
Mid-term and long-term results with directional atherectomy of vein graft stenoses. J Vasc Surg (1996) 0.78
Peripheral vascular complications of directional coronary atherectomy and stenting: predictors, management, and outcome. Am J Cardiol (1994) 0.78
Is carotid endarterectomy cost-effective in symptomatic patients with moderate (50% to 69%) stenosis? J Vasc Surg (1999) 0.78
Platelet-derived growth factor and extracellular matrix proteins provide a synergistic stimulus for human vascular smooth muscle cell migration. J Vasc Surg (1997) 0.78
Needle biopsy in the thorax. American College of Radiology. ACR Appropriateness Criteria. Radiology (2000) 0.78
Cross-sectional pattern of collateral vessels in patients with superficial femoral artery occlusion. Invest Radiol (2001) 0.77
Evolving strategies for the repair of complex renovascular lesions. Ann Surg (1987) 0.77
Inferior vena cava filter placement. American College of Radiology. ACR Appropriateness Criteria. Radiology (2000) 0.76
The cost-effectiveness of repairing ruptured abdominal aortic aneurysms. J Vasc Surg (2000) 0.75
'Medical cost savings through stroke prevention from 100 consecutive new carotid duplex scans', by G.S. Lavenson and D. Sharma, Cardiovascular Surgery, 1996, 4: 753-58. Cardiovasc Surg (1996) 0.75
Percutaneous biliary drainage in malignant biliary obstruction. American College of Radiology. ACR Appropriateness Criteria. Radiology (2000) 0.75
Is routine duplex ultrasound surveillance after carotid endarterectomy cost-effective? Surgery (1998) 0.75
Thrombolysis for native arterial occlusions of the lower extremities: clinical outcome and cost. J Vasc Surg (2001) 0.75
Anatomically tailored k-Space sampling for bolus-chase three-dimensional MR digital subtraction angiography. Radiology (2001) 0.75
Thrombolysis for lower extremity arterial and graft occlusions. American College of Radiology. ACR Appropriateness Criteria. Radiology (2000) 0.75
Piggy-back mesenteric arterial reconstruction. J Cardiovasc Surg (Torino) (1992) 0.75
Is thrombolysis of lower extremity acute arterial occlusion cost-effective? J Surg Res (1999) 0.75
Selecting stent grafts for the endovascular treatment of abdominal aortic aneurysms. J Cardiovasc Surg (Torino) (2003) 0.75
Elastic retraction for exposure of the femoral artery. Surg Gynecol Obstet (1990) 0.75
Iliac angioplasty. American College of Radiology. ACR Appropriateness Criteria. Radiology (2000) 0.75
Risk factors and their role in the diseases of the arterial wall. Semin Vasc Surg (1998) 0.75
Recessed elliptical-centric view-ordering for contrast-enhanced 3D MR angiography of the carotid arteries. Magn Reson Med (2002) 0.75
Endoluminal stent graft repair of traumatic thoracic aortic pseudoaneurysm. Eur J Vasc Endovasc Surg (2002) 0.75
Percutaneous transluminal renal angioplasty. American College of Radiology. ACR Appropriateness Criteria. Radiology (2000) 0.75
The role of mitogen-activated protein kinase and protein kinase C in fibronectin production in human vascular smooth muscle cells. J Surg Res (1999) 0.75
Gene therapy to prevent vein graft stenosis--ready for prime time? Cardiovasc Surg (2000) 0.75
The role of the vascular surgeon in endovascular procedures. J Vasc Surg (2001) 0.75
Carotid endarterectomy in asymptomatic patients--is contrast angiography necessary? A morbidity analysis. J Vasc Surg (1995) 0.75